
    
      This will be a randomized, prospective blinded pilot study comparing nesiritide to placebo in
      patients undergoing aortic arch, ascending aorta, aortic valve or mitral valve surgery with
      baseline GFR 30-90ml/min. Patients were randomized to either placebo or nesiritide
      (administered prophylactically starting in the operating room prior to incision at 0.01
      mcg/kg /minute with no bolus and continued for 48 hours).
    
  